These studies have evoked speculation about a possible therapeutic role for CRP in SLE, and it has been suggested that CRP exerts its proposed long-lasting protective effects by inducing interleukin-10 through engagement of Fcγ receptor I on macrophages (9). Here, IL10 is linked to systemic lupus erythematosus.